About US
Contact us
-
UPDATED: Senate proposes incentivizing generic drugmakers to help control price hikesAfter a yearlong investigation into rising drug prices, the U.S. Senate Special Committee on Aging has released areportthat seeks to provide solutions to a tough conundrum: Legislators don’t want the2017/1/20
-
Medicare Part B changes are dead and that’s good for pharma: reportEarlier this year, the Centers for Medicare and Medicaid Services (CMS) unveiled a plan to test a new payment model for Medicare Part B that would incentivize healthcare providers to use low-cost drug2017/1/19
-
U.K. authorities say Actavis broke competition law with 'excessive and unfair prices' on a genericFor the second time this month, officials in the U.K. there are taking issue with huge price hikes. The country's Competition and Markets Authority, which earlier this month hit Pfizer with a $108 mil2017/1/19
-
Pfizer finally convinces FDA to pull black-box warning on Chantix for psychotic side effectsSeven years after safety concerns altered the trajectory of Pfizer’s stop-smoking med Chantix, the FDA haspulledits black-box warning from the drug’s label. FDA officials removed the warning after2017/1/18
-
States follow feds with accusations of generic price fixing against Mylan, Heritage, othersGeneric drugmakers have received yet another holiday surprise. Just a day after federal authorities released the initial salvo into an alleged price-fixing scheme by charging two former Heritage Pharm2017/1/18
-
Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbusterScore a big win for Pfizer and its $4.5 billion buyout of Anacor Pharmaceuticals. The FDA Wednesday approved Anacor'seczema treatmentthat is projected to be a $2 billion blockbuster. The FDAapprovedE2017/1/17
-
Ex-Heritage Pharma execs first up for federal charges in generics price-fixing probeJust a month after details of a wide-ranging generics price fixing probe made their way to the public, the Justice Department has stepped forward with its first charges. Prosecutors are determined the2017/1/17
-
Bristol-Myers to pay $19.5 million in Abilify off-label marketing settlementAlmost a decade after settling up Abilify marketing allegations with the U.S. Justice Department, Bristol-Myers Squibb agreed to pay $19.5 million to settle similar claims at the state level. Announc2017/1/16
-
States follow feds with accusations of generic price fixing against Mylan, Heritage, othersGeneric drugmakers have received yet another holiday surprise. Just a day after federal authorities released the initial salvo into an alleged price-fixing scheme by charging two former Heritage Pharm2017/1/16
-
Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbusterScore a big win for Pfizer and its $4.5 billion buyout of Anacor Pharmaceuticals. The FDA Wednesday approved Anacor'seczema treatmentthat is projected to be a $2 billion blockbuster. The FDAapprovedE2017/1/13